Rezolute, Inc. (RZLT) income statement
RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.92−0.28 (-6.67%)
Close on Nov 20, 2026Market cap $379.15MP/E –Yield –
Rezolute, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -59.1%
Financial strength
- Current ratio
- 9.92
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 86.1%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 4.41
- Dividend yield
- –
See a number that looks wrong?